Article Text

Download PDFPDF
Systemic infection following intravesical therapy with BCG
  1. Ana Andrade Oliveira1,
  2. Joana Morais1,
  3. Jorge Ribeiro2 and
  4. Paulo Ferreira Gouveia1
  1. 1Department of Internal Medicine, Hospital de Braga, Braga, Portugal
  2. 2Department of Urology, Hospital de Braga, Braga, Portugal
  1. Correspondence to Dr Ana Andrade Oliveira; anaandradeoliveira100{at}gmail.com

Abstract

Immunotherapy with BCG is an effective and widely used treatment for non-muscle-invasive bladder cancer. BCG sepsis is a rare but life-threatening and frequently not a straightforward complication of this treatment; in cases with a high index of suspicion, anti-bacillary treatment should not wait for laboratory confirmation and be instituted immediately. We report a severe case of BCG sepsis, in which timely diagnosis and initiation of antituberculosis agents enabled a full recovery.

  • urology
  • urological cancer
  • TB and other respiratory infections

Statistics from Altmetric.com

Footnotes

  • Contributors AAO: conception and design of the article, acquisition of the data, interpretation of the data, drafting the article, revising it critically for important intellectual content and final approval of the article. JM: acquisition of the data, revising it critically for important intellectual content and final approval of the article. JR: design of the article, acquisition of the data, revising it critically for important intellectual content and final approval of the article. P-FG: conception and design of the article, acquisition of the data, interpretation of the data, revising it critically for important intellectual content and final approval of the article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.